Log in

Probiotec Stock Price, Forecast & Analysis (ASX:PBP)

+0.02 (+0.99 %)
(As of 11/17/2019 04:00 PM ET)
Today's Range
Now: A$2.04
50-Day Range
MA: A$1.94
52-Week Range
Now: A$2.04
Volume53,726 shs
Average VolumeN/A
Market Capitalization$152.55 million
P/E Ratio11.66
Dividend Yield1.73%
Probiotec Limited develops, manufactures, and sells pharmaceutical, consumer health, and nutraceutical products in Australia and internationally. The company operates in three segments: Branded Pharmaceuticals, Contract Manufacture, and Obesity and Weight Management. It primarily engages in the contract manufacturing of pharmaceutical, food, and animal nutrition products for pharmaceutical and food companies; manufacture and sale of a range of obesity and weight management products in various channels, including FMCG, pharmacy, health food stores, and online; and provision of Celebrity Slim and Impromy weight loss programs. The company also provides owned and licensed branded pharmaceutical products, over-the-counter pharmaceutical products, complementary medicines, and specialty ingredients. Probiotec Limited was founded in 1997 and is based in Laverton North, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Phone61 3 9278 7555



Sales & Book Value

Annual Sales$79.09 million
Cash FlowA$0.15 per share
Book ValueA$0.83 per share



Market Cap$152.55 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PBP News and Ratings via Email

Sign-up to receive the latest news and ratings for PBP and its competitors with MarketBeat's FREE daily newsletter.

Probiotec (ASX:PBP) Frequently Asked Questions

What is Probiotec's stock symbol?

Probiotec trades on the ASX under the ticker symbol "PBP."

How often does Probiotec pay dividends? What is the dividend yield for Probiotec?

Probiotec announced a Final dividend on Friday, September 13th. Stockholders of record on Thursday, October 31st will be given a dividend of 0.025 per share on Thursday, October 31st. This represents a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, October 24th. View Probiotec's Dividend History.

How were Probiotec's earnings last quarter?

Probiotec Limited (ASX:PBP) released its earnings results on Tuesday, February, 26th. The company reported $0.02 EPS for the quarter. View Probiotec's Earnings History.

Has Probiotec been receiving favorable news coverage?

Media headlines about PBP stock have been trending very negative this week, InfoTrie reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Probiotec earned a media sentiment score of -3.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Probiotec.

Who are some of Probiotec's key competitors?

Who are Probiotec's key executives?

Probiotec's management team includes the folowing people:
  • Mr. Wesley Stringer B.Comm, LLB (Hons), CPA, CEO, MD & Exec. Director
  • Mr. Jared Stringer, CFO, Company Sec. & Financial Controller
  • Ms. Julie McIntosh, Chief Operating Officer
  • Mr. Alan Hong, Gen. Mang. of Accounting
  • Mr. Dustin Stringer, Gen. Mang. of Marketing

What is Probiotec's stock price today?

One share of PBP stock can currently be purchased for approximately A$2.04.

How big of a company is Probiotec?

Probiotec has a market capitalization of $152.55 million and generates $79.09 million in revenue each year. View Additional Information About Probiotec.

What is Probiotec's official website?

The official website for Probiotec is http://www.probiotec.com.au/.

How can I contact Probiotec?

The company can be reached via phone at 61 3 9278 7555.

MarketBeat Community Rating for Probiotec (ASX PBP)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  22
MarketBeat's community ratings are surveys of what our community members think about Probiotec and other stocks. Vote "Outperform" if you believe PBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel